Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Atherosclerosis. 2015 Oct 24;243(2):533–539. doi: 10.1016/j.atherosclerosis.2015.10.095

Table 1. Characteristics of the study population.

Characteristic Total (N=100)
Age (years), Mean (SD) 50.48(2.63)
Race, N(%)
Black 27(27)
White 73(73)
Menopausal Status, N(%)
Premenopausal 50(50)
Postmenopausal 50(50)
Body mass index (kg/m2), Mean (SD) 28.66(5.92)
Current smoking, N(%) 15(15.15)
Use of Heart medication, N(%) 03(03)
HDL-C(mg/dl), Median(Q1, Q3) 57(48, 68)
LDL-C(mg/dl), Median(Q1, Q3) 120(105, 145)
Triglycerides(mg/dl), Median(Q1, Q3) 101(79, 144)
HOMA-IR, Median(Q1, Q3) 1.83(1.48, 2.75)
TAT (cm3), Median(Q1, Q3) 43.47(35.12, 66.59)
PVAT (cm3), Median(Q1, Q3) 27.31(22.73, 36.39)
C3 (mg/dl), Mean (SD) 162.3(33.28)
C4 (mg/dl), Mean (SD) 31.93(8.78)
Aortic calcification (AC) Agatston score, Median(Q1, Q3) 2.80(0, 4.67)
Presence of AC (AC>0), N(%) 67(67)
Coronary calcification (CAC) Agatston score, Median(Q1, Q3) 0(0, 2.29)
Presence of CAC (CAC>0), N(%) 48(48)